Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011

Current Opinion in Virology

Volumn 2, Issue 4, 2012, Pages 434-442

  Lopman, Ben A ^a   Payne, Daniel C ^a   Tate, Jacqueline E ^a   Patel, Manish M ^a   Cortese, Margaret M ^a   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ADVENTITIOUS PORCINE CIRCOVIRUS 1; AFRICA; AGE DISTRIBUTION; ARTICLE; ASIA; AUSTRALIA; AUSTRIA; BRAZIL; CIRCOVIRUS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTUSSUSCEPTION; ISRAEL; MEXICO; MORTALITY; NICARAGUA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VIRAL CONTAMINATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 84865145251     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.05.002     Document Type: Review

References (67)

1. Center for Disease Control Prevention (CDC) Rotavirus surveillance - worldwide, 2001-2008 MMWR. Morbidity and Mortality Weekly Report 57 2008 1255 1257
2. M.A. Widdowson, M.I. Meltzer, X. Zhang, J.S. Bresee, U.D. Parashar, and R.I. Glass Cost-effectiveness and potential impact of rotavirus vaccination in the United States Pediatrics 119 2007 684 697 (Pubitemid 46556667)
3. J.E. Tate, A.H. Burton, C. Boschi-Pinto, A.D. Steele, J. Duque, U.D. Parashar the WHOcGRSN 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis Lancet Infectious Diseases 12 2012 136 141 Most recent esdtimates of rotavirus related mortality: 450 000 death annually in children under 5 years. Will be an important benchmark against which to measure the impact of vaccination programs.
4. Center for Disease Control, and Prevention (CDC) Rotavirus surveillance worldwide - 2009 Weekly Epidemiological Record 86 2011 174 176
5. World Health O Rotavirus vaccines Weekly Epidemiological Record 82 2007 285 295
6. Center for Disease Control Prevention (CDC) Rotavirus vaccines: an update Weekly Epidemiological Record 84 2009 533 540
7. E.A. Nelson, and R.I. Glass Rotavirus: realising the potential of a promising vaccine Lancet 376 2010 568 570
8. M. O'Ryan, Y. Lucero, and A.C. Linhares Rotarix(R): vaccine performance 6 years postlicensure Expert Review of Vaccines 10 2011 1645 1659
9. J.E. Tate, M.M. Patel, M.M. Cortese, B.A. Lopman, J.R. Gentsch, J. Fleming, A.D. Steele, and U.D. Parashar Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality Expert Review of Vaccines 11 2012 211 220
10. R.I. Glass, M. Patel, and U. Parashar Lessons from the US rotavirus vaccination program JAMA: The Journal of the American Medical Association 306 2011 1701 1702
11. R.I. Glass Unexpected benefits of rotavirus vaccination in the United States Journal of Infectious Diseases 204 2011 975 977
12. M.A. Staat, D.C. Payne, S. Donauer, G.A. Weinberg, K.M. Edwards, P.G. Szilagyi, M.R. Griffin, C.B. Hall, A.T. Curns, and J.R. Gentsch Effectiveness of pentavalent rotavirus vaccine against severe disease Pediatrics 128 2011 e267 e275
13. J.P. Buttery, S.B. Lambert, K. Grimwood, M.D. Nissen, E.J. Field, K.K. Macartney, J.D. Akikusa, J.J. Kelly, and C.D. Kirkwood Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule Pediatric Infectious Disease Journal 30 2011 S25 S29
14. M. Paulke-Korinek, P. Rendi-Wagner, M. Kundi, R. Kronik, and H. Kollaritsch Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children Pediatric Infectious Disease Journal 29 2010 319 323
15. K. Muhsen, L. Shulman, E. Kasem, U. Rubinstein, J. Shachter, A. Kremer, S. Goren, I. Zilberstein, G. Chodick, and M. Ephros Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study Human Vaccines 6 2010 450 454
16. R.Q. Gurgel, J.B. Correia, and L.E. Cuevas Effect of rotavirus vaccination on circulating virus strains Lancet 371 2008 301 302 (Pubitemid 351754783)
17. M.C. Justino, A.C. Linhares, T.M. Lanzieri, Y. Miranda, J.D. Mascarenhas, E. Abreu, S.F. Guerra, A.S. Oliveira, V.B. da Silva, and N. Sanchez Effectiveness of the Monovalent G1P[8] Human Rotavirus Vaccine Against Hospitalization for Severe G2P[4] Rotavirus Gastroenteritis in Belem, Brazil Pediatric Infectious Disease Journal 30 2011 396 401
18. J.B. Correia, M.M. Patel, O. Nakagomi, F.M. Montenegro, E.M. Germano, N.B. Correia, L.E. Cuevas, U.D. Parashar, N.A. Cunliffe, and T. Nakagomi Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil Journal of Infectious Diseases 201 2011 363 369
19. C. Yen, J.R. Figueroa, E.S. Uribe, L.D. Carmen-Hernandez, J.E. Tate, U.D. Parashar, M.M. Patel, and V. Richardson Lopez-Collado Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico Journal of Infectious Diseases 204 2011 783 786
20. M. Patel, C. Pedreira, L.H. De Oliveira, J. Tate, M. Orozco, J. Mercado, A. Gonzalez, O. Malespin, J.J. Amador, and J. Umana Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua JAMA: The Journal of the American Medical Association 301 2009 2243 2251
21. T.C. Mast, S. Khawaja, F. Espinoza, M. Paniagua, L.P. Del Carmen, A. Cardellino, and E. Sanchez Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua Pediatric Infectious Disease Journal 30 2011 e209 e215
22. A.T. Curns, C.A. Steiner, M. Barrett, K. Hunter, E. Wilson, and U.D. Parashar Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states Journal of Infectious Diseases 201 2010 1617 1624
23. G.M. do Carmo, C. Yen, J. Cortes, A.A. Siqueira, W.K. de Oliveira, J.J. Cortez-Escalante, B. Lopman, B. Flannery, L.H. de Oliveira, and E.H. Carmo Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis PLoS Medicine 8 2011 e1001024
24. T.M. Lanzieri, A.C. Linhares, I. Costa, D.A. Kolhe, M.H. Cunha, E. Ortega-Barria, and R.E. Colindres Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil International Journal of Infectious Diseases 15 2011 e206 e210
25. Y. Molto, J.E. Cortes, L.H. De Oliveira, A. Mike, I. Solis, O. Suman, L. Coronado, M.M. Patel, U.D. Parashar, and M.M. Cortese Reduction of diarrhea-associated hospitalizations among children aged <5 years in Panama following the introduction of rotavirus vaccine Pediatric Infectious Disease Journal 30 2011 S16 S20
26. O. de Palma, L. Cruz, H. Ramos, A. de Baires, N. Villatoro, D. Pastor, L.H. de Oliveira, T. Kerin, M. Bowen, and J. Gentsch Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study BMJ: British Medical Journal 340 2010 c2825
27. M. Quintanar-Solares, C. Yen, V. Richardson, M. Esparza-Aguilar, U.D. Parashar, and M.M. Patel Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico Pediatric Infectious Disease Journal 30 2011 S11 S15
28. M.A. Safadi, E.N. Berezin, V. Munford, F.J. Almeida, J.C. de Moraes, C.F. Pinheiro, and M.L. Racz Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil Pediatric Infectious Disease Journal 29 2010 1019 1022
29. C. Yen, J.A. Armero Guardado, P. Alberto, D.S. Rodriguez Araujo, C. Mena, E. Cuellar, J.B. Nolasco, L.H. De Oliveira, D. Pastor, and J.E. Tate Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador Pediatric Infectious Disease Journal 30 2011 S6 S10
30. V. Richardson, J. Hernandez-Pichardo, M. Quintanar-Solares, M. Esparza-Aguilar, B. Johnson, C.M. Gomez-Altamirano, U. Parashar, and M. Patel Effect of rotavirus vaccination on death from childhood diarrhea in Mexico New England Journal of Medicine 362 2010 299 305
31. • ] all demonstrate a decrease in gastroenrteritis mortalirty consistent with what may be expected (in terms of seasonality and age patterns) from rotavirus vaccination.
32. M.L. Barreto, M.G. Teixeira, F.I. Bastos, R.A. Ximenes, R.B. Barata, and L.C. Rodrigues Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs Lancet 377 2011 1877 1889
33. D.C. Payne, M.A. Staat, K.M. Edwards, P.G. Szilagyi, G.A. Weinberg, C.B. Hall, J. Chappell, A.T. Curns, M. Wikswo, and J.E. Tate Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009 Clinical Infectious Diseases 53 2011 245 253
34. B.A. Lopman, A.T. Curns, C. Yen, and U.D. Parashar Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States Journal of Infectious Diseases 204 2011 980 986 Taken together, the above two refeerences and reference [13], strongly suggest that rotavirus vaccines are also conferring indirect protection to both unvaccinated children as adults.
35. V.E. Pitzer, C. Viboud, L. Simonsen, C. Steiner, C.A. Panozzo, W.J. Alonso, M.A. Miller, R.I. Glass, J.W. Glasser, and U.D. Parashar Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics Science 325 2009 290 294
36. J.E. Tate, C.A. Panozzo, D.C. Payne, M.M. Patel, M.M. Cortese, A.L. Fowlkes, and U.D. Parashar Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine Pediatrics 124 2009 465 471
37. G. Hanquet, G. Ducoffre, A. Vergison, P. Neels, M. Sabbe, P. Van Damme, and K. Van Herck Impact of rotavirus vaccination on laboratory confirmed cases in Belgium Vaccine 29 2011 4698 4703
38. A.C. Linhares, F.R. Velazquez, I. Perez-Schael, X. Saez-Llorens, H. Abate, F. Espinoza, P. Lopez, M. Macias-Parra, E. Ortega-Barria, and D.M. Rivera-Medina Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study Lancet 371 2008 1181 1189 (Pubitemid 351458523)
39. T. Vesikari, A. Karvonen, R. Prymula, V. Schuster, J.C. Tejedor, R. Cohen, F. Meurice, H.H. Han, S. Damaso, and A. Bouckenooghe Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study Lancet 370 2007 1757 1763 (Pubitemid 350137490)
40. C.D. Kirkwood, K. Boniface, G.L. Barnes, and R.F. Bishop Distribution of rotavirus genotypes after introduction of rotavirus vaccines. Rotarix(R) and RotaTeq(R), into the National Immunization Program of Australia Pediatric Infectious Disease Journal 30 2011 S48 S53
41. J.A. Boom, J.E. Tate, L.C. Sahni, M.A. Rench, J.J. Hull, J.R. Gentsch, M.M. Patel, C.J. Baker, and U.D. Parashar Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States Pediatrics 125 2010 e199 e207
42. S.N. Desai, D.B. Esposito, E.D. Shapiro, P.H. Dennehy, and M. Vazquez Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA Vaccine 28 2010 7501 7506
43. T. Vesikari, D.O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodriguez, M.J. Dallas, J.F. Heyse, M.G. Goveia, and S.B. Black Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine New England Journal of Medicine 354 2006 23 33 (Pubitemid 43048948)
44. C.C. Chang, M.H. Chang, T.Y. Lin, H.C. Lee, W.S. Hsieh, and P.I. Lee Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan Journal of the Formosan Medical Association 108 2009 280 285
45. J.J. Hull, E.N. Teel, T.K. Kerin, M.M. Freeman, M.D. Esona, J.R. Gentsch, M.M. Cortese, U.D. Parashar, R.I. Glass, and M.D. Bowen United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction Pediatric Infectious Disease Journal 30 2011 S42 S47
46. M.M. Patel, L.H. de Oliveira, A.M. Bispo, J. Gentsch, and U.D. Parashar Rotavirus P[4]G2 in a vaccinated population, Brazil Emerging Infectious Diseases 14 2008 863 865
47. V.E. Pitzer, M.M. Patel, B.A. Lopman, C. Viboud, U.D. Parashar, and B.T. Grenfell Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions Proceedings of the National Academy of Sciences of the United States of America 108 2011 19353 19358
48. G.M. Ruiz-Palacios, I. Perez-Schael, F.R. Velazquez, H. Abate, T. Breuer, S.C. Clemens, B. Cheuvart, F. Espinoza, P. Gillard, and B.L. Innis Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis New England Journal of Medicine 354 2006 11 22 (Pubitemid 43048947)
49. M.M. Patel, V.R. Lopez-Collada, M.M. Bulhoes, L.H. De Oliveira, A. Bautista Marquez, B. Flannery, M. Esparza-Aguilar, E.I. Montenegro Renoiner, M.E. Luna-Cruz, and H.K. Sato Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil New England Journal of Medicine 364 2011 2283 2292 There appears to be a small risk if intussusception, at least after the first dose of RV5 in Mexico, though the risks of this adverse event is heavily outweghed by the benefits of vaccination.
50. J.P. Buttery, M.H. Danchin, K.J. Lee, J.B. Carlin, P.B. McIntyre, E.J. Elliott, R. Booy, J.E. Bines, and P.A.S. Group Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia Vaccine 29 2011 3061 3066
51. I.M. Shui, J. Baggs, M. Patel, U.D. Parashar, M. Rett, E.A. Belongia, S.J. Hambidge, J.M. Glanz, N.P. Klein, and E. Weintraub Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants JAMA: The Journal of the American Medical Association 307 2012 598 604
52. H.B. Greenberg Rotavirus vaccination and intussusception - act two New England Journal of Medicine 364 2011 2354 2355
53. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) Summary Report October 27-28, 2010. http://www.cdc.gov/vaccines/recs/acip/downloads/min-archive/min-oct10.pdf.
54. Rotavirus vaccine and intussusception:report from an expert consultation. Weekly Epidemiological Record 2011, 86:317-321.
55. J.G. Victoria, C. Wang, M.S. Jones, C. Jaing, K. McLoughlin, S. Gardner, and E.L. Delwart Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus Journal of Virology 84 2010 6033 6040 Detection of an adventitionus agent (porcine circovirus) in RV1, which also led ot the discovery of PCV fragments in RV5, raised an unexpected saftey concern, as well as a general debate about the role of ultra-sensitive molecular techiniquies as a tool for assessing vaccine saftey.
56. S.D. McClenahan, P.R. Krause, and C. Uhlenhaut Molecular and infectivity studies of porcine circovirus in vaccines Vaccine 29 2011 4745 4753
57. US Food and Drug Administration: http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm211101.htm. vol 2/15/2012.
58. D.D. Dore, B.R. Turnbull, and J.D. Seeger Vaccine discontinuation and switching following regulatory interventions in response to rotavirus vaccine contamination with porcine circovirus DNA fragments Pharmacoepidemiology and Drug Safety 21 2012 415 419
59. D.C. Payne, S. Humiston, D. Opel, A. Kennedy, M. Wikswo, K. Downing, E.J. Klein, A. Kobayashi, D. Locke, and C. Albertin A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus BMC Pediatrics 11 2011 83
60. M. Bouzon Alejandro, J. Diez Domingo, and F. Martinon-Torres Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain Human Vaccines 7 2011 798 799
61. Babi S, Kang G: Rotavirus vaccination in developing countries. Current Opinion in Virology, http://dx.doi.org/10.1016/j.coviro.2012.05.005
62. T. Vesikari, A.V. Karvonen, J. Majuri, S.Q. Zeng, X.L. Pang, R. Kohberger, B.D. Forrest, Y. Hoshino, R.M. Chanock, and A.Z. Kapikian Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children Journal of Infectious Diseases 194 2006 370 376 (Pubitemid 44116980)
63. N. Bhandari, P. Sharma, S. Taneja, T. Kumar, T. Rongsen-Chandola, M.B. Appaiahgari, A. Mishra, S. Singh, and S. Vrati A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial Journal of Infectious Diseases 200 2009 421 429
64. G.L. Barnes, J.S. Lund, S.V. Mitchell, L. De Bruyn, L. Piggford, A.L. Smith, J. Furmedge, P.J. Masendycz, H.C. Bugg, and N. Bogdanovic-Sakran Early phase II trial of human rotavirus vaccine candidate RV3 Vaccine 20 2002 2950 2956 (Pubitemid 34785966)
65. Y. Wang, M. Azevedo, L.J. Saif, J.R. Gentsch, R.I. Glass, and B. Jiang Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets Vaccine 28 2010 5432 5436
66. T. Luan le, N.V. Trang, N.M. Phuong, H.T. Nguyen, H.T. Ngo, H.T. Nguyen, H.B. Tran, H.N. Dang, A.D. Dang, and J.R. Gentsch Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam Vaccine 27 Suppl. 5 2009 F130 F138
67. J.E. Tate, J.D. Mutuc, C.A. Panozzo, D.C. Payne, M.M. Cortese, J.E. Cortes, C. Yen, D.H. Esposito, B.A. Lopman, and M.M. Patel Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006 Pediatric Infectious Disease Journal 30 2011 S30 S34